UBX0101

· Unity Biotechnology, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for UBX0101, covering 2021-12-29 to 2021-12-29. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Assess the Safety and Efficacy of a Single Dose of UBX0101 in Patients With Osteoarthritis of the Knee [Phase 2]

See pricing